Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial

Abstract Background Optimal strategies to facilitate implementation of evidence-based clinical pathways are unclear. We evaluated two implementation strategies (Core versus Enhanced) to facilitate implementation of a clinical pathway for the management of anxiety and depression in cancer patients (t...

Full description

Bibliographic Details
Main Authors: Phyllis Butow, Mona M. Faris, Joanne Shaw, Patrick Kelly, Sharon He, Marnie Harris, Jessica Cuddy, Lindy Masya, Liesbeth Geerligs, Brian Kelly, Afaf Girgis, Nicole Rankin, Philip Beale, Thomas F. Hack, Laura Kirsten, Haryana Dhillon, Peter Grimison, Rosalie Viney, Josephine M. Clayton, Timothy Schlub, The ADAPT Program Group, Heather L. Shepherd
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Implementation Science
Subjects:
Online Access:https://doi.org/10.1186/s13012-023-01269-0
_version_ 1827939770356989952
author Phyllis Butow
Mona M. Faris
Joanne Shaw
Patrick Kelly
Sharon He
Marnie Harris
Jessica Cuddy
Lindy Masya
Liesbeth Geerligs
Brian Kelly
Afaf Girgis
Nicole Rankin
Philip Beale
Thomas F. Hack
Laura Kirsten
Haryana Dhillon
Peter Grimison
Rosalie Viney
Josephine M. Clayton
Timothy Schlub
The ADAPT Program Group
Heather L. Shepherd
author_facet Phyllis Butow
Mona M. Faris
Joanne Shaw
Patrick Kelly
Sharon He
Marnie Harris
Jessica Cuddy
Lindy Masya
Liesbeth Geerligs
Brian Kelly
Afaf Girgis
Nicole Rankin
Philip Beale
Thomas F. Hack
Laura Kirsten
Haryana Dhillon
Peter Grimison
Rosalie Viney
Josephine M. Clayton
Timothy Schlub
The ADAPT Program Group
Heather L. Shepherd
author_sort Phyllis Butow
collection DOAJ
description Abstract Background Optimal strategies to facilitate implementation of evidence-based clinical pathways are unclear. We evaluated two implementation strategies (Core versus Enhanced) to facilitate implementation of a clinical pathway for the management of anxiety and depression in cancer patients (the ADAPT CP). Methods Twelve cancer services in NSW Australia were cluster randomised, stratified by service size, to the Core versus Enhanced implementation strategy. Each strategy was in place for 12 months, facilitating uptake of the ADAPT CP (the intervention being implemented). The Core strategy included a lead team with champions, staff training and awareness campaigns prior to implementation, plus access to feedback reports and telephone or online support during implementation. The Enhanced strategy included all Core supports plus monthly lead team meetings, and proactive, ongoing advice on managing barriers, staff training and awareness campaigns throughout implementation. All patients at participating sites were offered the ADAPT CP as part of routine care, and if agreeable, completed screening measures. They were allocated a severity step for anxiety/depression from one (minimal) to five (severe) and recommended management appropriate to their severity step. Multi-level mixed-effect regression analyses examined the effect of Core versus Enhanced implementation strategy on adherence to the ADAPT CP (binary primary outcome: adherent ≥ 70% of key ADAPT CP components achieved versus non-adherent < 70%), with continuous adherence as a secondary outcome. Interaction between study arm and anxiety/depression severity step was also explored. Results Of 1280 registered patients, 696 (54%) completed at least one screening. As patients were encouraged to re-screen, there were in total 1323 screening events (883 in Core and 440 in Enhanced services). The main effect of implementation strategy on adherence was non-significant in both binary and continuous analyses. Anxiety/depression step was significant, with adherence being higher for step 1 than for other steps (p = 0.001, OR = 0.05, 95% CI 0.02–0.10). The interaction between study arm and anxiety/depression step was significant (p = 0.02) in the continuous adherence analysis only: adherence was significantly higher (by 7.6% points (95% CI 0.08–15.1%) for step 3 in the Enhanced arm (p = .048) and trending to significance for step 4. Discussion These results support ongoing implementation effort for the first year of implementation to ensure successful uptake of new clinical pathways in over-burdened clinical services. Trial registration ANZCTR Registration: ACTRN12617000411347 (Trial registered 22/03/2017; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372486&isReview=true )
first_indexed 2024-03-13T08:59:22Z
format Article
id doaj.art-69e817e8ef6c45648d7b259a725f0a8e
institution Directory Open Access Journal
issn 1748-5908
language English
last_indexed 2024-03-13T08:59:22Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Implementation Science
spelling doaj.art-69e817e8ef6c45648d7b259a725f0a8e2023-05-28T11:23:38ZengBMCImplementation Science1748-59082023-05-0118111810.1186/s13012-023-01269-0Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trialPhyllis Butow0Mona M. Faris1Joanne Shaw2Patrick Kelly3Sharon He4Marnie Harris5Jessica Cuddy6Lindy Masya7Liesbeth Geerligs8Brian Kelly9Afaf Girgis10Nicole Rankin11Philip Beale12Thomas F. Hack13Laura Kirsten14Haryana Dhillon15Peter Grimison16Rosalie Viney17Josephine M. Clayton18Timothy Schlub19The ADAPT Program GroupHeather L. Shepherd20School of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneySchool of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneySchool of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneySchool of Public Health, Faculty of Medicine and Health, The University of SydneySchool of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneySchool of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneySchool of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneySchool of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneySchool of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneySchool of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneySouth West Sydney Clinical Campuses, UNSW Medicine & Health, University of New South WalesFaculty of Medicine and Health, The University of SydneyDepartment of Medical Oncology, Concord HospitalCollege of Nursing, Rady Faculty of Health Sciences, University of ManitobaNepean Hospital, Nepean Cancer Care CentreSchool of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneyChris O’Brien LifehouseCamperdownCentre for Health Economics Research and Evaluation, University of TechnologyHammondCare, The Palliative Centre, Greenwich HospitalSchool of Public Health, Faculty of Medicine and Health, The University of SydneySchool of Psychology, Psycho-Oncology Co-operative Research Group (PoCoG), The University of SydneyAbstract Background Optimal strategies to facilitate implementation of evidence-based clinical pathways are unclear. We evaluated two implementation strategies (Core versus Enhanced) to facilitate implementation of a clinical pathway for the management of anxiety and depression in cancer patients (the ADAPT CP). Methods Twelve cancer services in NSW Australia were cluster randomised, stratified by service size, to the Core versus Enhanced implementation strategy. Each strategy was in place for 12 months, facilitating uptake of the ADAPT CP (the intervention being implemented). The Core strategy included a lead team with champions, staff training and awareness campaigns prior to implementation, plus access to feedback reports and telephone or online support during implementation. The Enhanced strategy included all Core supports plus monthly lead team meetings, and proactive, ongoing advice on managing barriers, staff training and awareness campaigns throughout implementation. All patients at participating sites were offered the ADAPT CP as part of routine care, and if agreeable, completed screening measures. They were allocated a severity step for anxiety/depression from one (minimal) to five (severe) and recommended management appropriate to their severity step. Multi-level mixed-effect regression analyses examined the effect of Core versus Enhanced implementation strategy on adherence to the ADAPT CP (binary primary outcome: adherent ≥ 70% of key ADAPT CP components achieved versus non-adherent < 70%), with continuous adherence as a secondary outcome. Interaction between study arm and anxiety/depression severity step was also explored. Results Of 1280 registered patients, 696 (54%) completed at least one screening. As patients were encouraged to re-screen, there were in total 1323 screening events (883 in Core and 440 in Enhanced services). The main effect of implementation strategy on adherence was non-significant in both binary and continuous analyses. Anxiety/depression step was significant, with adherence being higher for step 1 than for other steps (p = 0.001, OR = 0.05, 95% CI 0.02–0.10). The interaction between study arm and anxiety/depression step was significant (p = 0.02) in the continuous adherence analysis only: adherence was significantly higher (by 7.6% points (95% CI 0.08–15.1%) for step 3 in the Enhanced arm (p = .048) and trending to significance for step 4. Discussion These results support ongoing implementation effort for the first year of implementation to ensure successful uptake of new clinical pathways in over-burdened clinical services. Trial registration ANZCTR Registration: ACTRN12617000411347 (Trial registered 22/03/2017; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372486&isReview=true )https://doi.org/10.1186/s13012-023-01269-0Implementation strategiesCluster randomised controlled trialAnxiety and depression management
spellingShingle Phyllis Butow
Mona M. Faris
Joanne Shaw
Patrick Kelly
Sharon He
Marnie Harris
Jessica Cuddy
Lindy Masya
Liesbeth Geerligs
Brian Kelly
Afaf Girgis
Nicole Rankin
Philip Beale
Thomas F. Hack
Laura Kirsten
Haryana Dhillon
Peter Grimison
Rosalie Viney
Josephine M. Clayton
Timothy Schlub
The ADAPT Program Group
Heather L. Shepherd
Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial
Implementation Science
Implementation strategies
Cluster randomised controlled trial
Anxiety and depression management
title Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial
title_full Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial
title_fullStr Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial
title_full_unstemmed Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial
title_short Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial
title_sort effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care a cluster randomised controlled trial
topic Implementation strategies
Cluster randomised controlled trial
Anxiety and depression management
url https://doi.org/10.1186/s13012-023-01269-0
work_keys_str_mv AT phyllisbutow effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT monamfaris effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT joanneshaw effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT patrickkelly effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT sharonhe effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT marnieharris effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT jessicacuddy effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT lindymasya effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT liesbethgeerligs effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT briankelly effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT afafgirgis effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT nicolerankin effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT philipbeale effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT thomasfhack effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT laurakirsten effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT haryanadhillon effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT petergrimison effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT rosalieviney effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT josephinemclayton effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT timothyschlub effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT theadaptprogramgroup effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial
AT heatherlshepherd effectofcoreversusenhancedimplementationstrategiesonadherencetoaclinicalpathwayformanaginganxietyanddepressionincancerpatientsinroutinecareaclusterrandomisedcontrolledtrial